Glomeria Therapeutics
Develops and commercialises medical devices to treat nephropathy.
Launch date
Employees
Market cap
-
Enterprise valuation
$4—7m (Dealroom.co estimates Sep 2015.)
Company register number MI2525082
Chieti Abruzzo (HQ)
Financials
Estimates*
| EUR | 2015 | 2016 | 2017 |
|---|---|---|---|
| Revenues | <1m | <1m | <1m |
| % growth | - | 3031 % | 71 % |
| EBITDA | (<1m) | (1.3m) | <1m |
| % EBITDA margin | (170959 %) | (10016 %) | 335 % |
| Profit | (<1m) | (5.3m) | (<1m) |
| % profit margin | (193934 %) | (40242 %) | (387 %) |
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Seed | ||
€1.0m | Early VC | ||
€2.8m | Grant | ||
€2.8m | Grant | ||
| Total Funding | $7.3m | ||